高瓴拟接盘!603259,28亿元大动作

中国基金报
Oct 26

【导读】药明康德拟28亿元向高瓴出售资产,预计助力2025年度净利润  中国基金报记者闻言  10月26日晚间,药明康德发布公告称,公司全资子公司上海药明康德新药开发有限公司拟以28亿元的基准股权转让价款,向高瓴投资旗下私募股权基金成立的公司转让从事临床研究服务业务的资产,预计对公司2025年度净利润产生较大的积极影响。  同日,药明康德发布的2025年三季报显示,公司2025年前三季度的归母...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10